We are live on ! Find out more
LVACW

LAVA Medtech Acquisition Corp. Warrants
LVACW

Delisted

LVACW was delisted on the 12th of May, 2023.

32 hedge funds and large institutions have $2.92M invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

39% more capital invested

Capital invested by funds: $2.09M → $2.92M (+$825K)

10% more funds holding

Funds holding: 2932 (+3)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
4
Closed
2
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
+$9K
Name Holding Trade Value Shares
Change
Change in
Stake
WA
26
Whitebox Advisors
Minnesota
$3K
SSA
27
Schonfeld Strategic Advisors
New York
$3K +$5.1K +25,000 New
CM
28
Cohanzick Management
New York
$3K +$5.57K +27,278 New
AllianceBernstein
29
AllianceBernstein
Tennessee
$1K
DCM
30
Dupont Capital Management
Delaware
$1K
GL
31
Governors Lane
New York
-$86K -245,000 Closed
CCM
32
Context Capital Management
California
-$23K -66,400 Closed
GCL
33
Glazer Capital LLC
New York
-$2.9K -14,200 -98%

LVACW Hedge Fund Activity: Q2 2022 in Review

32 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q2 2022, worth a combined $2.92M — up 39% from $2.09M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new LVACW positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Fort Baker Capital Management, opening a new position worth an estimated $50K. The largest seller was Governors Lane, exiting entirely with an estimated $86K sold.

  • 32 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q2 2022, up from 29 in Q1 2022.
  • Funds reported $2.92M of LAVA Medtech Acquisition Corp. Warrants stock for Q2 2022, up 39% quarter-over-quarter.
  • 5 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q2 2022 and 2 closed out, a net change of +3 holders.
  • The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q2 2022 was Fort Baker Capital Management, an estimated $50K added.
  • The largest LAVA Medtech Acquisition Corp. Warrants seller in Q2 2022 was Governors Lane, an estimated $86K sold.

Based on aggregated 13F filings for Q2 2022.